公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
2012 | Agreement assessment of tigecycline susceptibilities determined by the disk diffusion and broth microdilution methods among commonly encountered resistant bacterial isolates: Results from the Tigecycline in Vitro Surveillance in Taiwan (TIST) study, 2008 to 2010 | Liu J.-W.; Ko W.-C.; Huang C.-H.; Liao C.-H.; Lu C.-T.; Chuang Y.-C.; Tsao S.-M.; Chen Y.-S.; Liu Y.-C.; Chen W.-Y.; Jang T.-N.; Lin H.-C.; Chen C.-M.; Shi Z.-Y.; SUNG-CHING PAN ; Yang J.-L.; HSIANG-CHI KUNG ; Liu C.-E.; Cheng Y.-J.; Chen Y.-H.; Lu P.-L.; Sun W.; Wang L.-S.; Yu K.-W.; Chiang P.-C.; Lee M.-H.; Lee C.-M.; Hsu G.-J.; PO-REN HSUEH | Antimicrobial Agents and Chemotherapy | 29 | 27 | |
2012 | Changing trends in antimicrobial susceptibility of Streptococcus pneumoniae isolates in Taiwan, 2006-2007 | Li C.-F.; Liu M.-F.; Shi Z.-Y.; PO-REN HSUEH ; Liao C.-H.; Jang T.-N.; Tsao S.-M.; HSIANG-CHI KUNG ; Hsu G.-J.; Cheng Y.-J.; Lin H.-C.; Liu Y.-C.; Chuang Y.-C.; Wang L.-S.; Chen C.-M. | Journal of Microbiology, Immunology and Infection | 10 | 9 | |
2013 | Clinical outcomes of tigecycline alone or in combination with other antimicrobial agents for the treatment of patients with healthcare-associated multidrug-resistant Acinetobacter baumannii infections | Lee Y.-T.; Tsao S.-M.; PO-REN HSUEH | European Journal of Clinical Microbiology and Infectious Diseases | 51 | 46 | |
2009 | Corrigendum to "Nationwide surveillance in Taiwan of the in-vitro activity of tigecycline against clinical isolates of Gram-positive cocci" [Int. J. Antimicrob. Agents 32 (2008) S184-S187] (PII:S0924-8579(08)X0017-2) | Tsao S.-M.; Lin H.-C.; Lee C.-M.; Hsu G.-J.; Chen C.-M.; Sun W.; Liu Y.-C.; Jang T.-N.; Cheng Y.-J.; Lu P.-L.; Chiang P.-C.; Wang L.-S.; HSIANG-CHI KUNG ; Chuang Y.-C.; Shi Z.-Y.; Liu J.-W.; Huang C.-H.; Lu C.-T.; Liao C.-H.; PO-REN HSUEH | International Journal of Antimicrobial Agents | 17 | 0 | |
2010 | Decline in the incidence of healthcare-associated methicillin-resistant Staphylococcus aureus (HA-MRSA) correlates with deceased antimicrobial consumption at a tertiary care hospital in Taiwan, 2001-2009 | Lee Y.-T.; Tsao S.-M.; Lin H.-C.; Huang H.-J.; Lee M.-C.; PO-REN HSUEH | International Journal of Antimicrobial Agents | 6 | 5 | |
2012 | Does empirical treatment of community-acquired pneumonia with fluoroquinolones delay tuberculosis treatment and result in fluoroquinolone resistance in Mycobacterium tuberculosis? Controversies and solutions | Shen G.-H.; Tsao T.C.-Y.; Kao S.-J.; Lee J.-J.; Chen Y.-H.; Hsieh W.-C.; Hsu G.-J.; Hsu Y.-T.; Huang C.-T.; Lau Y.-J.; Tsao S.-M.; PO-REN HSUEH | International Journal of Antimicrobial Agents | 28 | 24 | |
2014 | Erratum to: Clinical outcomes of tigecycline alone or in combination with other antimicrobial agents for the treatment of patients with healthcare-associated multidrug-resistant Acinetobacter baumannii infections | Lee Y.-T.; Tsao S.-M.; PO-REN HSUEH | European Journal of Clinical Microbiology and Infectious Diseases | 1 | 1 | |
2006 | Extended-spectrum β-lactamases and plasmid-mediated AmpC enzymes among clinical isolates of Escherichia coli and Klebsiella pneumoniae from seven medical centers in Taiwan | Yan J.-J.; PO-REN HSUEH ; Lu J.-J.; Chang F.-Y.; Shyr J.-M.; Wan J.-H.; Liu Y.-C.; Chuang Y.-C.; Yang Y.-C.; Tsao S.-M.; Wu H.-H.; Wang L.-S.; Lin T.-P.; Wu H.-M.; Chen H.-M.; Wu J.-J. | Antimicrobial Agents and Chemotherapy | 56 | 39 | |
2008 | In-vitro activity of tigecycline against clinical isolates of Acinetobacter baumannii in Taiwan | Liu J.-W.; Wang L.-S.; Cheng Y.-J.; Hsu G.-J.; Lu P.-L.; Liu Y.-C.; Chen C.-M.; Lee C.-M.; Sun W.; Jang T.-N.; Chiang P.-C.; Chuang Y.-C.; Lin H.-C.; Shi Z.-Y.; HSIANG-CHI KUNG ; Huang C.-H.; Tsao S.-M.; Lu C.-T.; Liao C.-H.; PO-REN HSUEH | International Journal of Antimicrobial Agents | 16 | 17 | |
2008 | In-vitro activity of tigecycline against clinical isolates of Acinetobacter baumannii in Taiwan determined by the broth microdilution and disk diffusion methods | Liao C.-H.; HSIANG-CHI KUNG ; Hsu G.-J.; Lu P.-L.; Liu Y.-C.; Chen C.-M.; Lee C.-M.; Sun W.; Jang T.-N.; Chiang P.-C.; Cheng Y.-J.; Lin H.-C.; Shi Z.-Y.; Wang L.-S.; Chuang Y.-C.; Tsao S.-M.; Lu C.-T.; Liu J.-W.; Huang C.-H.; PO-REN HSUEH | International Journal of Antimicrobial Agents | 16 | 13 | |
2008 | Nationwide surveillance in Taiwan of the in-vitro activity of tigecycline against clinical isolates of extended-spectrum β-lactamase-producing Enterobacteriaceae | Lu C.-T.; Chuang Y.-C.; Sun W.; Liu Y.-C.; Cheng Y.-J.; Lu P.-L.; Chen C.-M.; Hsu G.-J.; Jang T.-N.; Lee C.-M.; Chiang P.-C.; Shi Z.-Y.; Wang L.-S.; HSIANG-CHI KUNG ; Lin H.-C.; Liao C.-H.; Liu J.-W.; Huang C.-H.; Tsao S.-M.; PO-REN HSUEH | International Journal of Antimicrobial Agents | 10 | 10 | |
2008 | Nationwide surveillance in Taiwan of the in-vitro activity of tigecycline against clinical isolates of Gram-positive cocci | Tsao S.-M.; Lin H.-C.; Lee C.-M.; Hsu G.-J.; Chen C.-M.; Sun W.; Liu Y.-C.; Jang T.-N.; Cheng Y.-J.; Lu P.-L.; Chiang P.-C.; Wang L.-S.; HSIANG-CHI KUNG ; Chuang Y.-C.; Shi Z.-Y.; Liu J.-W.; Huang C.-H.; Lu C.-T.; Liao C.-H.; PO-REN HSUEH | International Journal of Antimicrobial Agents | 6 | 6 | |
2007 | An observational study on the empiric use of cefpirome in febrile neutropenia | Su Y.-C.; Sheu Y.-T.; Peng M.-Y.; Yeh K.-M.; CHAO-YUAN HUANG ; Wang S.-M.; Chang Y.-F.; Chang M.-C.; Wu M.-F.; Tsao S.-M. | Journal of Microbiology, Immunology and Infection | 4 | 0 | |
2010 | Prevalence and accessory gene regulator (agr) analysis of vancomycin-intermediate Staphylococcus aureus among methicillin-resistant isolates in Taiwan-SMART program, 2003 | Ho C.-M.; PO-REN HSUEH ; Liu C.-Y.; Lee S.-Y.; Chiueh T.-S.; Shyr J.-M.; Tsao S.-M.; Chuang Y.-C.; Yan J.-J.; Wang L.-S.; Wang J.-H.; Ho M.-W.; Tien N.; Lu J.-J. | European Journal of Clinical Microbiology and Infectious Diseases | 39 | 31 | |
2019 | Safety and efficacy of oral nemonoxacin versus levofloxacin in treatment of community-acquired pneumonia: A phase 3, multicenter, randomized, double-blind, double-dummy, active-controlled, non-inferiority trial | Yuan J.; Mo B.; Ma Z.; Lv Y.; Cheng S.-L.; Yang Y.; Tong Z.; Wu R.; Sun S.; Cao Z.; Wu J.; Zhu D.; Chang L.; Zhang Y.; Zhao L.; Wang X.; Wang X.; Wang D.; Li X.; Peng Y.; Liang Y.; Liu H.; Xiao Z.; Lv X.; Wu S.; Dai Y.; Huang Y.; Hu Z.; Qiu C.; Li X.; Zhang S.; Li W.; Liu S.; Shi Y.; Xiong C.; Kuang J.; Xiu Q.; Cui S.; Li J.; Lin Q.; Huang W.; Wan Y.; Qimanguli, Shen C.; Xiao Y.; Wu X.; Chuang Y.C.; Perng W.C.; Tsao S.-M.; Hsu J.-Y.; Wang C.-C.; Wang J.-H.; Yeh P.-F.; Lin H.-H.; PING-HUNG KUO ; Lin M.-S.; Su W.-J.; Investigator Group of the Phase 3 Study on Oral Nemonoxacin | Journal of Microbiology, Immunology and Infection | 28 | 26 | |
2021 | Successful treatment of a critical COVID-19 patient with tocilizumab | Tsao S.-M.; JANN-YUAN WANG ; Li C.-F.; Hsieh M.-C.; Wang Y.-T.; Chan K.-C.; Pan H.-H.; Lee Y.-T.; Huang Y.-W. | Journal of the Formosan Medical Association | 1 | 0 | |
2012 | Trends in susceptibility of vancomycin-resistant Enterococcus faecium to tigecycline, daptomycin, and linezolid and molecular epidemiology of the isolates: Results from the Tigecycline in Vitro Surveillance in Taiwan (TIST) study, 2006 to 2010 | Tsai H.-Y.; Liao C.-H.; Chen Y.-H.; Lu P.-L.; Huang C.-H.; Lu C.-T.; Chuang Y.-C.; Tsao S.-M.; Chen Y.-S.; Liu Y.-C.; Chen W.-Y.; Jang T.-N.; Lin H.-C.; Chen C.-M.; Shi Z.-Y.; SUNG-CHING PAN ; Yang J.-L.; HSIANG-CHI KUNG ; Liu C.-E.; Cheng Y.-J.; Liu J.-W.; Sun W.; Wang L.-S.; Ko W.-C.; Yu K.-W.; Chiang P.-C.; Lee M.-H.; Lee C.-M.; Hsu G.-J.; PO-REN HSUEH | Antimicrobial Agents and Chemotherapy | 20 | 19 | |
2013 | Trends in the antimicrobial susceptibilities and serotypes of Streptococcus pneumoniae: Results from the Tigecycline in Vitro Surveillance in Taiwan (TIST) study, 2006-2010 | Tsai H.-Y.; Chen Y.-H.; Liao C.-H.; Lu P.-L.; Huang C.-H.; Lu C.-T.; Chuang Y.-C.; Tsao S.-M.; Chen Y.-S.; Liu Y.-C.; Chen W.-Y.; Jang T.-N.; Lin H.-C.; Chen C.-M.; Shi Z.-Y.; SUNG-CHING PAN ; Yang J.-L.; HSIANG-CHI KUNG ; Liu C.-E.; Cheng Y.-J.; Liu J.-W.; Sun W.; Wang L.-S.; Ko W.-C.; Yu K.-W.; Chiang P.-C.; Lee M.-H.; Lee C.-M.; Hsu G.-J.; PO-REN HSUEH | International Journal of Antimicrobial Agents | 11 | 11 | |
2012 | Trends in the susceptibility of clinically important resistant bacteria to tigecycline: Results from the tigecycline In Vitro surveillance in Taiwan study, 2006 to 2010 | Chen Y.-H.; Lu P.-L.; Huang C.-H.; Liao C.-H.; Lu C.-T.; Chuang Y.-C.; Tsao S.-M.; Chen Y.-S.; Liu Y.-C.; Chen W.-Y.; Jang T.-N.; Lin H.-C.; Chen C.-M.; Shi Z.-Y.; SUNG-CHING PAN ; Yang J.-L.; HSIANG-CHI KUNG ; Liu C.-E.; Cheng Y.-J.; Liu J.-W.; Sun W.; Wang L.-S.; Ko W.-C.; Yu K.-W.; Chiang P.-C.; Lee M.-H.; Lee C.-M.; Hsu G.-J.; PO-REN HSUEH | Antimicrobial Agents and Chemotherapy | 39 | 35 | |
2014 | Trends in the susceptibility of methicillin-resistant Staphylococcus aureus to nine antimicrobial agents, including ceftobiprole, nemonoxacin, and tyrothricin: Results from the Tigecycline in Vitro Surveillance in Taiwan (TIST) study, 2006-2010 | Chen Y.-H.; Liu C.-Y.; Ko W.-C.; Liao C.-H.; Lu P.-L.; Huang C.-H.; Lu C.-T.; Chuang Y.-C.; Tsao S.-M.; Chen Y.-S.; Liu Y.-C.; Chen W.-Y.; Jang T.-N.; Lin H.-C.; Chen C.-M.; Shi Z.-Y.; SUNG-CHING PAN ; Yang J.-L.; HSIANG-CHI KUNG ; Liu C.-E.; Cheng Y.-J.; Liu J.-W.; Sun W.; Wang L.-S.; Yu K.-W.; Chiang P.-C.; Lee M.-H.; Lee C.-M.; Hsu G.-J.; PO-REN HSUEH | European Journal of Clinical Microbiology and Infectious Diseases | 22 | 19 | |